BioStable Science Engineering, Inc. is developing innovative new products for the treatment of cardiovascular disease. BioStable is led by an experienced group of industry executives with expertise in rapid and effective medical device development. Their organization incorporates core strengths in all areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. BioStable provides a competitive edge by minimizing time to market for cost effective medical devices that deliver improved clinical outcomes. BioStable is currently developing the HAART device, intended for use in aortic valve repair and valve sparing procedures, in partnership with J. Scott Rankin, MD, a Nashville-based cardiac surgeon.